Other
Randomised Controlled Trial
0
Pipeline Programs↗
7
Active Trials↗
1
Companies Involved↗
Randomised Controlled Trial is an early-stage landscape with 0 programs across 1 company. The most active players are S.L.A. Pharma AG.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
33
clinical trials
Completed18 · 55%
Unknown status6 · 18%
Recruiting4 · 12%
Terminated2 · 6%
Not yet recruiting2 · 6%
Active, not recruiting1 · 3%
Clinical Trials
Trial Activity
33 trials
Evaluation of Effect of Platelet-Rich Fibrin on Orthodontic Tooth Movement: a Split Mouth Randomised Controlled Trial
Recruiting·—·Phase 1/2·NCT06634017·15 enrolled
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
Completed·—·Phase 2·NCT02111161·100 enrolled
Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial
Completed·ZZekai Tahir Burak Women's Health Research and Education Hospital·Phase 4·NCT05311540·195 enrolled
Efficacy and Safety of Remimazolam Compared With Midazolam During Bronchoscopy:Randomised Controlled Trial
Completed·—·Phase 4·NCT05994547·100 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)